Search Results

The dynamic relation between management control and governance structure in a supply chain context

Authors: Veen-Dirks, Paula M.G. van; Verdaasdonk, Peter J.A.

Source: Supply Chain Management: An International Journal, Volume 14, Number 6, 2009 , pp. 466-478(13)

Publisher: Emerald Group Publishing Limited

Micafungin appears to be cost saving versus caspofungin when used to treat candidaemia and invasive candidiasis

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 589, 2009-10-17 , pp. 8-8(1)

Publisher: Adis International

Ambrisentan is less costly than other endothelin receptor antagonists (ERAs) but more expensive than sildenafil for the treatment of pulmonary arterial hypertension

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 9-9(1)

Publisher: Adis International

Use of a comprehensive multimodal analgesic regimen could significantly lower costs of major orthopaedic surgery

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 585, 2009-08-22 , pp. 9-9(1)

Publisher: Adis International

Insulin glargine, a sweet choice for diabetes mellitus

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 582, 2009-07-11 , pp. 5-6(2)

Publisher: Adis International

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

Authors: Maniadakis, Nikos; Fragoulakis, Vasilios; Pectasides, Dimitrios; Fountzilas, George

Source: Current Medical Research and Opinion, Volume 25, Number 3, March 2009 , pp. 797-805(9)

Publisher: Informa Healthcare

A 100mg daily dose of micafungin delivers similar outcomes for patients with candidaemia as a 150mg dose, at lower costs

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 581, 2009-06-27 , pp. 8-8(1)

Publisher: Adis International

Optimising immune tolerance induction strategies in the management of haemophilia patients with inhibitors: a cost-minimisation analysis

Authors: Odeyemi, Isaac A. O.; Danø, Anne M.

Source: Current Medical Research and Opinion, Volume 25, Number 1, January 2009 , pp. 239-250(12)

Publisher: Informa Healthcare

Daptomycin creates a niche in skin and skin-structure infections

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 579, 2009-05-30 , pp. 3-3(1)

Publisher: Adis International

A capecitabine plus oxaliplatin regimen [XELOX] is less costly than a fluorouracil, folinic acid and oxaliplatin regimen [FOLFOX6]

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 577, 2009-05-02 , pp. 8-8(1)

Publisher: Adis International

No difference in costs of vancomycin, teicoplanin

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 570, 2009-01-24 , pp. 4-4(1)

Publisher: Adis International

GI cancer news from ASCO

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 571, 2009-02-07 , pp. 4-5(2)

Publisher: Adis International

Moxifloxacin, levofloxacin costs compared at Chest 2008

Source: Inpharma, Volume 1, Number 1667, 2008-12-06 , pp. 7-7(1)

Publisher: Adis International

Teleconsultation in remote care stations: cost-minimisation analysis of the Guianese experiment

Authors: Nassiri, N.; Goff-Pronost, M. Le; Nassiri, A.

Source: International Journal of Biomedical Engineering and Technology, Volume 2, Number 1, 9 December 2008 , pp. 74-87(14)

Publisher: Inderscience Publishers

Moxifloxacin, levofloxacin costs compared at Chest 2008

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 568, 2008-12-13 , pp. 4-4(1)

Publisher: Adis International

It pays to pick beclometasone/formoterol for asthma in Spain

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 566, 2008-11-15 , pp. 9-9(1)

Publisher: Adis International

It pays to pick beclometasone/formoterol for asthma in Spain

Source: Inpharma, Volume 1, Number 1664, 2008-11-15 , pp. 6-6(1)

Publisher: Adis International

Cancer news from ISPOR

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 567, 2008-11-29 , pp. 6-7(2)

Publisher: Adis International

Cancer news from ISPOR

Source: Inpharma, Volume 1, Number 1666, 2008-11-29 , pp. 7-8(2)

Publisher: Adis International

Moxifloxacin cost saving for community-acquired pneumonia

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 554, 2008-05-31 , pp. 4-4(1)

Publisher: Adis International